ENDPOINTS

Monte Rosa reports first data for molecular glue program

Monte Rosa Therapeutics reported Phase 1 data Thursday morning for a Novartis-partnered program that the companies believe could change the treatment paradigm for some immune-mediated diseases. Though the data come from healthy volunteers, observers are ...

Mar 20, 2025 - 12:50
 0
Monte Rosa reports first data for molecular glue program
Monte Rosa Therapeutics reported Phase 1 data Thursday morning for a Novartis-partnered program that the companies believe could change the treatment paradigm for some immune-mediated diseases. Though the data come from healthy volunteers, observers are ...
Read More

Tags:

Previous Article

‘Don’t call it zombie deer disease’: scientists warn of ‘global crisis’ as infec...

Next Article

How is head hair different from body hair? 

Related Posts

Merck dodges ‘failure to warn’ claims in federal Gardasil cases

Merck dodges ‘failure to warn’ claims in federal Gardas...

Mar 11, 2025  0

Novartis returns for its anticoagulant in up to $3.1B buy of Blackstone’s Anthos

Novartis returns for its anticoagulant in up to $3.1B b...

Feb 11, 2025  0

FDA and NIH nominees sail through Senate hearings; Tariffs’ early impact on drug manufacturing; AbbVie’s move into the obesity market; and more

FDA and NIH nominees sail through Senate hearings; Tari...

Mar 8, 2025  0